Last updated at 01 Jul 2024 12:57 AM
Director
DIN: 08048769
Roshu Chetan Shetty is currently associated with 4 companies in various capacities such as Director, Designated Partner, Partner and Individual Promoter. They serve as a Director at SCLEPIUS HEALTHCARE PRIVATE LIMITED and have other roles in different companies. They are registered with the Ministry of Corporate Affairs (MCA) of India and hold a DIN of 08048769.Roshu Chetan Shetty is currently involved in 4 different roles. Their most recent position is with XIMING HEALTHCARE PRIVATE LIMITED as a Director. The first company Roshu Chetan Shetty was appointed to as a director was SCLEPIUS HEALTHCARE PRIVATE LIMITED. Roshu Chetan Shetty is not disqualified by the Registrar of Companies under Section 164(2), and their DIN has not been deactivated due to failure to file the DIR-3 KYC Form.
Roshu Chetan Shetty is currently associated with 4 companies in various capacities such as Director, Designated Partner, Partner and Individual Promoter. They serve as a Director at SCLEPIUS HEALTHCARE PRIVATE LIMITED and have other roles in different companies. They are registered with the Ministry of Corporate Affairs (MCA) of India and hold a DIN of 08048769.Roshu Chetan Shetty is currently involved in 4 different roles. Their most recent position is with XIMING HEALTHCARE PRIVATE LIMITED as a Director. The first company Roshu Chetan Shetty was appointed to as a director was SCLEPIUS HEALTHCARE PRIVATE LIMITED. Roshu Chetan Shetty is not disqualified by the Registrar of Companies under Section 164(2), and their DIN has not been deactivated due to failure to file the DIR-3 KYC Form.
5
Female
India
Gain instant access to verified contact details.
Current Companies (2)
Current LLPs (2)
Past Companies (0)
1y 7m 10 Months Interval
| Company Name | Designation | Date of Appointment |
|---|---|---|
| SCLEPIUS HEALTHCARE PRIVATE LIMITED | Director | 11-Jan-2018 |
| XIMING HEALTHCARE PRIVATE LIMITED | Director | 25-May-2022 |
| XIMING HEALTHCARE PRIVATE LIMITED | Individual Promoter | 25-May-2022 |